Sanguinate™ (Pegylated carboxyhemoglobin bovine) improves cerebral blood flow to vulnerable brain regions at risk of delayed cerebral ischemia after subarachnoid hemorrhage. by Prolong Pharma | Dec 1, 2017 | Publications
Pegylated bovine carboxyhaemoglobin utilisation in a thrombotic thrombocytopenic purpura patient by Prolong Pharma | Aug 1, 2017 | Publications
SANGUINATE (PEGylated Carboxyhemoglobin Bovine): Mechanism of Action and Clinical Update. by Prolong Pharma | Apr 1, 2017 | Publications
Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers by Prolong Pharma | Mar 1, 2017 | Publications
A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia. by Prolong Pharma | Mar 1, 2017 | Publications
Determination of methemoglobin and hemoglobin levels in small volume samples by Prolong Pharma | Feb 1, 2017 | Publications